Published date: 1 October 2019

Last edited date: 1 October 2019

This notice was replaced on 4 November 2019

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Future opportunity (published 4 November 2019)

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Contract summary

Industry

  • Blood products - 33141510

Location of contract

Any region

Value of contract

£15,000,000

Procurement reference

CM/PHS/17/5551

Published date

1 October 2019

Approach to market date

1 February 2020

Contract start date

1 July 2020

Contract end date

30 June 2021

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Human Cell Line Recombinant Factor VIII

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2020/2021 £11,250,000
2021/2022 £3,750,000

About the buyer

Address

Commercial Medicines Unit
2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

wendy.roach@nhs.net